Market Tracker

11/26 6:05pm ET

SPDR® Barclays Long Term Corporate Bond ETF (LWC)

Data as of Nov 26
 +0.165 / +0.40%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of an index that tracks the long term (10+ years) sector of the United States corporate bond market. The fund employs a sampling strategy in seeking to track the performance of the Barclays U.S. Long Term Corporate Bond Index. It invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in securities that have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise the index. The fund is non-diversified.

No recent news for SPDR® Barclays Long Term Corporate Bond ETF.


1 month+0.26% 3 years+7.29%
3 months+0.10% 5 years+8.35%
1 year+14.78% Since inception+11.51%
Data through 11/26/2014

Quote Details

Previous close$41.00
Open day’s range41.10 – 41.25
Net asset value (NAV)40.66 (11/25/2014)
Daily volume168,830
Average volume (3 months)91,947
Data as of 3:59pm ET, 11/26/2014

Peer Comparisonvs. Corporate bond ETFs

Performance 5-yr return+8.35%+6.07%
Expense Gross exp ratio0.15%0.21%
Risk 5 year sharpe ratio1.041.39
Net assets$239.5M$982.8M
Average market cap----
Average P/E----
Dividend / Share--0.20%


CBND SPDR® Barclays Issuer Scored Corporate ...
VCIT Vanguard Intermediate-Term Corporate Bon...
CRED iShares Core U.S. Credit Bond ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- Verizon Comms 6.55%1.13%
-- Goldman Sachs Grp 6.75%0.66%
-- General Elec Cap Corp Mtn Be 5.875%0.63%
-- Verizon Comms 6.4%0.59%
-- Verizon Comms 144A 4.862%0.57%
-- General Elec Cap Corp Mtn Be 6.75%0.55%
-- Wal-Mart Stores 6.5%0.50%
-- General Elec Cap Corp Mtn Be 6.875%0.49%
-- France Telec 31 SrN0.44%
-- Glaxosmithkline Cap 6.375%0.43%